December 2025

11 December 2025

Walk in for Freshers in Quality Control at Ipca Laboratories - BPharm, BSc Apply

Upon successful completion of the training, selected candidates will be absorbed at Ipca Laboratories, Athal (Silvassa) as per compatibility and skills.

11 December 2025

Walk in Drive for M.Pharm, B.Pharm, MSc in Manufacturing, Packing, Store & Warehouse at Amneal Pharma

Looking for candidates with relevant experience in Injectable regulated plant for Manufacturing, Packing & Store & Warehouse Department at SEZ Matoda Location

11 December 2025

Opportunity in Quality Assurance at Biocon Biologics | M.Pharm, B.Pharm, MSc Apply

Specifications, Method Validations / Transfers, Investigations, Audit Trail, Stability, Batch Release, Analytical, Molecular & Bioassay Techniques.

11 December 2025

Interviews for M.Pharm, B.Pharm, MSc in Warehouse, R&D, QC Departments at Vital Pharma

Invoice Entries, Billing Entries, take care of material weighing, go down Stock checking. Loading, Unloading Checking, Handling of storage checking and issuing of material from Go down.

11 December 2025

Interview for M.Pharm, B.Pharm, MSc in Analytical Development Department at Indoco Remedies

Analytical method development of finished dosage forms. Stability studies of finished dosage forms. Analytical method validation Analytical method transfer.

11 December 2025

HiMedia Laboratories Hiring Production In-charge

Seeking a highly motivated and results-driven Production In-charge to oversee the manufacturing operations for our range of high-quality DNA/RNA Extraction Kits and Lateral Flow Kits

11 December 2025

Novo Nordisk has completed its acquisition of Akero Therapeutics

Novo Nordisk and Akero Therapeutics Inc. announced that Novo Nordisk’s acquisition of Akero, announced on 9 October 2025, has been completed.

11 December 2025

Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer

Roche announced today positive data from the phase III lidERA Breast Cancer study evaluating investigational giredestrant as an adjuvant endocrine treatment for people with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative, early-stage breast cancer.

11 December 2025

Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health

Zealand Pharma A/S, a biotechnology company transforming the future of metabolic health, today presents its strategy for redefining the near-term future of weight management and its vision to establish leadership in metabolic health at its Capital Markets Day in London.